Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 498

1.

Doripenem for treating nosocomial pneumonia and ventilator-associated pneumonia - Authors' reply.

Kollef MH, Réa-Neto Á, Wunderink RG, Bruno CJ, Rhee EG.

Lancet Infect Dis. 2020 Jan;20(1):20-21. doi: 10.1016/S1473-3099(19)30717-0. No abstract available.

PMID:
31876489
2.

Impact of baseline characteristics on future episodes of bloodstream infections: Multistate model in septic patients with bloodstream infections.

Vazquez Gusillamet MC, Vazquez R, Noe J, Micek ST, Fraser VJ, Kollef MH.

Clin Infect Dis. 2019 Dec 20. pii: ciz1206. doi: 10.1093/cid/ciz1206. [Epub ahead of print]

PMID:
31858141
3.

Microbiologic Failure Despite Clinical Cure in Pneumonia: Cum Hoc and Post Hoc Ergo Propter Hoc.

Shorr AF, Spellberg B, Zilberberg MD, Kollef MH.

Clin Infect Dis. 2019 Dec 13. pii: ciz1191. doi: 10.1093/cid/ciz1191. [Epub ahead of print] No abstract available.

PMID:
31832646
4.

Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP).

Tabah A, Bassetti M, Kollef MH, Zahar JR, Paiva JA, Timsit JF, Roberts JA, Schouten J, Giamarellou H, Rello J, De Waele J, Shorr AF, Leone M, Poulakou G, Depuydt P, Garnacho-Montero J.

Intensive Care Med. 2019 Nov 28. doi: 10.1007/s00134-019-05866-w. [Epub ahead of print]

PMID:
31781835
5.

Outcomes of Macrolide Deescalation in Severe Community-acquired Pneumonia.

Hopkins TM, Juang P, Weaver K, Kollef MH, Betthauser KD.

Clin Ther. 2019 Dec;41(12):2540-2548. doi: 10.1016/j.clinthera.2019.10.005. Epub 2019 Oct 29.

PMID:
31676040
6.

Redefining the Threshold for Broad-Spectrum Antibiotics.

Michelson AP, Kollef MH.

Ann Am Thorac Soc. 2019 Nov;16(11):1367-1369. doi: 10.1513/AnnalsATS.201908-608ED. No abstract available.

PMID:
31674818
7.

Pathogen-Negative Sepsis-An Opportunity for Antimicrobial Stewardship.

Lockhart GC, Hanin J, Micek ST, Kollef MH.

Open Forum Infect Dis. 2019 Oct 9;6(10):ofz397. doi: 10.1093/ofid/ofz397. eCollection 2019 Oct.

8.

Clinical Effect of Expedited Pathogen Identification and Susceptibility Testing for Gram-Negative Bacteremia and Candidemia by Use of the Accelerate PhenoTM System.

Burnham JP, Wallace MA, Fuller BM, Shupe A, Burnham CD, Kollef MH.

J Appl Lab Med. 2019 Jan;3(4):569-579. doi: 10.1373/jalm.2018.027201. Epub 2018 Nov 30.

9.

Protocol for a prospective, observational cohort study of awareness in mechanically ventilated patients admitted from the emergency department: the ED-AWARENESS study.

Pappal RD, Roberts BW, Mohr NM, Ablordeppey E, Wessman BT, Drewry AM, Yan Y, Kollef MH, Avidan MS, Fuller BM.

BMJ Open. 2019 Oct 7;9(10):e033379. doi: 10.1136/bmjopen-2019-033379.

10.

Novel Approaches to Hasten Detection of Pathogens and Antimicrobial Resistance in the Intensive Care Unit.

Guillamet MCV, Burnham JP, Kollef MH.

Semin Respir Crit Care Med. 2019 Aug;40(4):454-464. doi: 10.1055/s-0039-1693160. Epub 2019 Oct 4.

PMID:
31585472
11.

Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial.

Kollef MH, Nováček M, Kivistik Ü, Réa-Neto Á, Shime N, Martin-Loeches I, Timsit JF, Wunderink RG, Bruno CJ, Huntington JA, Lin G, Yu B, Butterton JR, Rhee EG.

Lancet Infect Dis. 2019 Dec;19(12):1299-1311. doi: 10.1016/S1473-3099(19)30403-7. Epub 2019 Sep 25.

PMID:
31563344
12.

The ED-SED Study: A Multicenter, Prospective Cohort Study of Practice Patterns and Clinical Outcomes Associated With Emergency Department SEDation for Mechanically Ventilated Patients.

Fuller BM, Roberts BW, Mohr NM, Knight WA 4th, Adeoye O, Pappal RD, Marshall S, Alunday R, Dettmer M, Goyal M, Gibson C, Levine BJ, Gardner-Gray JM, Mosier J, Dargin J, Mackay F, Johnson NJ, Lokhandwala S, Hough CL, Tonna JE, Tsolinas R, Lin F, Qasim ZA, Harvey CE, Bassin B, Stephens RJ, Yan Y, Carpenter CR, Kollef MH, Avidan MS.

Crit Care Med. 2019 Nov;47(11):1539-1548. doi: 10.1097/CCM.0000000000003928.

PMID:
31393323
13.

Moving the Practice of Respiratory Therapy Forward.

Kollef MH, Watts P.

Respir Care. 2019 Aug;64(8):1014-1016. doi: 10.4187/respcare.07017. No abstract available.

PMID:
31346076
14.

Factors Associated With Clinical Deterioration Among Patients Hospitalized on the Wards at a Tertiary Cancer Hospital.

Lyons PG, Klaus J, McEvoy CA, Westervelt P, Gage BF, Kollef MH.

J Oncol Pract. 2019 Aug;15(8):e652-e665. doi: 10.1200/JOP.18.00765. Epub 2019 Jul 15.

15.

Vancomycin/Pipiercillin-Tazobactam Nephrotoxicity in the Critically Ill.

Kollef MH, Juang P, Micek ST.

Clin Infect Dis. 2019 Jul 11. pii: ciz643. doi: 10.1093/cid/ciz643. [Epub ahead of print] No abstract available.

PMID:
31297504
16.

Cluster analysis to define distinct clinical phenotypes among septic patients with bloodstream infections.

Guilamet MCV, Bernauer M, Micek ST, Kollef MH.

Medicine (Baltimore). 2019 Apr;98(16):e15276. doi: 10.1097/MD.0000000000015276.

17.

Rebuttal From Drs Aguilar and Kollef.

Aguilar PR, Kollef MH.

Chest. 2019 Apr;155(4):668-669. doi: 10.1016/j.chest.2018.11.017. No abstract available.

PMID:
30955570
18.

POINT: Does Persistent or Worsening ARDS Refractory to Optimized Ventilation and Proning Deserve a Trial of Prostacyclin? Yes.

Aguilar PR, Kollef MH.

Chest. 2019 Apr;155(4):662-665. doi: 10.1016/j.chest.2018.11.018. No abstract available.

PMID:
30955568
19.

Reduction in antimicrobial use among medical intensive care unit patients during a cluster randomized crossover trial of palliative care consultation.

Burnham JP, Chi S, Ma J, Dans MC, Kollef MH.

Infect Control Hosp Epidemiol. 2019 Apr;40(4):491-492. doi: 10.1017/ice.2019.34. Epub 2019 Mar 6. No abstract available.

PMID:
30838966
20.

New antibiotics for community-acquired pneumonia.

Kollef MH, Betthauser KD.

Curr Opin Infect Dis. 2019 Apr;32(2):169-175. doi: 10.1097/QCO.0000000000000526.

PMID:
30640820
21.

Outcomes Associated With De-escalating Therapy for Methicillin-Resistant Staphylococcus aureus in Culture-Negative Nosocomial Pneumonia.

Cowley MC, Ritchie DJ, Hampton N, Kollef MH, Micek ST.

Chest. 2019 Jan;155(1):53-59. doi: 10.1016/j.chest.2018.10.014. Epub 2018 Oct 25.

PMID:
30621854
22.

Antibiotic Thresholds for Sepsis and Septic Shock.

Kollef MH, Burnham JP.

Clin Infect Dis. 2019 Aug 30;69(6):938-940. doi: 10.1093/cid/ciy1035. No abstract available.

23.

Duration of Exposure to Antipseudomonal β-Lactam Antibiotics in the Critically Ill and Development of New Resistance.

Teshome BF, Vouri SM, Hampton N, Kollef MH, Micek ST.

Pharmacotherapy. 2019 Mar;39(3):261-270. doi: 10.1002/phar.2201. Epub 2019 Jan 7.

PMID:
30506852
24.

The carbon footprint of treating patients with septic shock in the intensive care unit.

McGain F, Burnham JP, Lau R, Aye L, Kollef MH, McAlister S.

Crit Care Resusc. 2018 Dec;20(4):304-312.

25.

Re-estimating annual deaths due to multidrug-resistant organism infections.

Burnham JP, Olsen MA, Kollef MH.

Infect Control Hosp Epidemiol. 2019 Jan;40(1):112-113. doi: 10.1017/ice.2018.304. Epub 2018 Nov 22. No abstract available.

26.

Is Zero Ventilator-Associated Pneumonia Achievable?: Practical Approaches to Ventilator-Associated Pneumonia Prevention.

Vazquez Guillamet C, Kollef MH.

Clin Chest Med. 2018 Dec;39(4):809-822. doi: 10.1016/j.ccm.2018.08.004. Review.

PMID:
30390751
27.

Protocol for a multicentre, prospective cohort study of practice patterns and clinical outcomes associated with emergency department sedation for mechanically ventilated patients: the ED-SED Study.

Fuller BM, Mohr NM, Roberts BW, Carpenter CR, Kollef MH, Avidan MS.

BMJ Open. 2018 Oct 21;8(10):e023423. doi: 10.1136/bmjopen-2018-023423.

28.

Catheter removal and outcomes of multidrug-resistant central-line-associated bloodstream infection.

Burnham JP, Rojek RP, Kollef MH.

Medicine (Baltimore). 2018 Oct;97(42):e12782. doi: 10.1097/MD.0000000000012782.

29.

The most recent concepts for the management of bacterial and fungal infections in ICU.

Bassetti M, Poulakou G, Kollef MH.

Intensive Care Med. 2018 Nov;44(11):2000-2003. doi: 10.1007/s00134-018-5400-9. Epub 2018 Oct 6. No abstract available.

PMID:
30293148
30.

Postoperative Pneumonia Prevention in Pulmonary Resections: A Feasibility Pilot Study.

Semenkovich TR, Frederiksen C, Hudson JL, Subramanian M, Kollef MH, Patterson GA, Kreisel D, Meyers BF, Kozower BD, Puri V.

Ann Thorac Surg. 2019 Jan;107(1):262-270. doi: 10.1016/j.athoracsur.2018.08.008. Epub 2018 Oct 3.

31.

Response.

Shorr AF, Kollef MH.

Chest. 2018 Jul;154(1):224. doi: 10.1016/j.chest.2018.02.028. No abstract available.

PMID:
30044736
32.

Diagnosis and Treatment of Acute Respiratory Distress Syndrome.

Fuller BM, Mohr NM, Kollef MH.

JAMA. 2018 Jul 17;320(3):305-306. doi: 10.1001/jama.2018.5928. No abstract available.

PMID:
30027241
33.

Prevention of hospital-acquired pneumonia.

Lyons PG, Kollef MH.

Curr Opin Crit Care. 2018 Oct;24(5):370-378. doi: 10.1097/MCC.0000000000000523. Review.

PMID:
30015635
34.

Using wearable technology to predict health outcomes: a literature review.

Burnham JP, Lu C, Yaeger LH, Bailey TC, Kollef MH.

J Am Med Inform Assoc. 2018 Sep 1;25(9):1221-1227. doi: 10.1093/jamia/ocy082. Review.

PMID:
29982520
35.

Differences in mortality between infections due to extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.

Burnham JP, Kwon JH, Olsen MA, Babcock HM, Kollef MH.

Infect Control Hosp Epidemiol. 2018 Sep;39(9):1138-1139. doi: 10.1017/ice.2018.142. Epub 2018 Jul 2. No abstract available.

36.

The authors reply.

Roberts BW, Mohr NM, Ablordeppey E, Drewry AM, Ferguson IT, Trzeciak S, Kollef MH, Fuller BM.

Crit Care Med. 2018 Jul;46(7):e718-e719. doi: 10.1097/CCM.0000000000003110. No abstract available.

37.

Acinetobacter Pneumonia: Improving Outcomes With Early Identification and Appropriate Therapy.

Vazquez Guillamet C, Kollef MH.

Clin Infect Dis. 2018 Oct 15;67(9):1455-1462. doi: 10.1093/cid/ciy375. Review.

PMID:
29741597
38.

Clinical epidemiology of carbapenem-resistant gram-negative sepsis among hospitalized patients: Shifting burden of disease?

Britt NS, Ritchie DJ, Kollef MH, Burnham CD, Durkin MJ, Hampton NB, Micek ST.

Am J Infect Control. 2018 Oct;46(10):1092-1096. doi: 10.1016/j.ajic.2018.03.013. Epub 2018 Apr 26.

39.

Erratum for Drusano et al., "Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia".

Drusano GL, Corrado ML, Girardi G, Ellis-Grosse EJ, Wunderink RG, Donnelly H, Leeper KV, Brown M, Malek T, Hite RD, Ferrari M, Djureinovic D, Kollef MH, Mayfield L, Doyle A, Chastre J, Combes A, Walsh TJ, Dorizas K, Alnuaimat H, Morgan BE, Rello J, Mazo CA, Jones RN, Flamm RK, Woosley L, Ambrose PG, Bhavnani S, Rubino CM, Bulik CC, Louie A, Vicchiarelli M, Berman C.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e00198-18. doi: 10.1128/AAC.00198-18. Print 2018 Apr. No abstract available.

40.

Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections.

Burnham JP, Olsen MA, Stwalley D, Kwon JH, Babcock HM, Kollef MH.

Open Forum Infect Dis. 2018 Mar 15;5(3):ofy026. doi: 10.1093/ofid/ofy026. eCollection 2018 Mar.

41.

Frequent Versus Infrequent Monitoring of Endotracheal Tube Cuff Pressures.

Letvin A, Kremer P, Silver PC, Samih N, Reed-Watts P, Kollef MH.

Respir Care. 2018 May;63(5):495-501. doi: 10.4187/respcare.05926. Epub 2018 Jan 30.

42.

Importance of Site of Infection and Antibiotic Selection in the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Sepsis.

Britt NS, Ritchie DJ, Kollef MH, Burnham CA, Durkin MJ, Hampton NB, Micek ST.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02400-17. doi: 10.1128/AAC.02400-17. Print 2018 Apr.

43.

Sepsis-Associated Coagulopathy Severity Predicts Hospital Mortality.

Lyons PG, Micek ST, Hampton N, Kollef MH.

Crit Care Med. 2018 May;46(5):736-742. doi: 10.1097/CCM.0000000000002997.

PMID:
29373360
44.

Emergency department hyperoxia is associated with increased mortality in mechanically ventilated patients: a cohort study.

Page D, Ablordeppey E, Wessman BT, Mohr NM, Trzeciak S, Kollef MH, Roberts BW, Fuller BM.

Crit Care. 2018 Jan 18;22(1):9. doi: 10.1186/s13054-017-1926-4.

45.

Thirty-day hospital readmissions among mechanically ventilated emergency department patients.

Page DB, Drewry AM, Ablordeppey E, Mohr NM, Kollef MH, Fuller BM.

Emerg Med J. 2018 Apr;35(4):252-256. doi: 10.1136/emermed-2017-206651. Epub 2018 Jan 5.

PMID:
29305381
46.

Treatment of severe skin and soft tissue infections: a review.

Burnham JP, Kollef MH.

Curr Opin Infect Dis. 2018 Apr;31(2):113-119. doi: 10.1097/QCO.0000000000000431. Review.

47.

The Burden of Viruses in Pneumonia Associated With Acute Respiratory Failure: An Underappreciated Issue.

Shorr AF, Fisher K, Micek ST, Kollef MH.

Chest. 2018 Jul;154(1):84-90. doi: 10.1016/j.chest.2017.12.005. Epub 2017 Dec 21.

PMID:
29274318
48.

Association Between Partial Pressure of Arterial Carbon Dioxide and Survival to Hospital Discharge Among Patients Diagnosed With Sepsis in the Emergency Department.

Roberts BW, Mohr NM, Ablordeppey E, Drewry AM, Ferguson IT, Trzeciak S, Kollef MH, Fuller BM.

Crit Care Med. 2018 Mar;46(3):e213-e220. doi: 10.1097/CCM.0000000000002918.

49.

Readmissions With Multidrug-Resistant Infection in Patients With Prior Multidrug Resistant Infection.

Burnham JP, Kwon JH, Olsen MA, Babcock HM, Kollef MH.

Infect Control Hosp Epidemiol. 2018 Jan;39(1):12-19. doi: 10.1017/ice.2017.254. Epub 2017 Dec 17.

50.

Monocyte Function and Clinical Outcomes in Febrile and Afebrile Patients With Severe Sepsis.

Drewry AM, Ablordeppey EA, Murray ET, Dalton CM, Fuller BM, Kollef MH, Hotchkiss RS.

Shock. 2018 Oct;50(4):381-387. doi: 10.1097/SHK.0000000000001083.

Supplemental Content

Loading ...
Support Center